Dawkins et al. [46] reported that high KMT2D levels correlated with worse prognosis in patients with pancreatic cancer and that KMT2D positively regulated cell cycle genes in several pancreatic cancer cell lines. The gene discussed is KMT2D; the disease is familial pancreatic carcinoma.